eXoZymes, Inc. (EXOZ) Balance Sheet
EXOZ balance sheet, 2025
December 31, 2025 · U.S. dollars$6.0M assets = $2.6M liabilities + $3.4M equity
Both columns are drawn to the same scale: what EXOZ owns equals what it owes plus shareholders’ equity. Hover a block for its value.
EXOZ financial health
Descriptive bands, not a rating. Fiscal 2025.
EXOZ balance sheet trends, 2021–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $2.3M2021 | $6.0M2025 | +26.3%/yr | |
| Total liabilities | $1.1M2021 | $2.6M2025 | +22.3%/yr | |
| Shareholders’ equity | $1.2M2021 | $3.4M2025 | +29.8%/yr | |
| Cash & short-term investments | $547,8062021 | $3.0M2025 | +53.5%/yr | |
| Total debt | $720,6272021 | $1.2M2025 | +14.6%/yr | |
| Net cash (debt) | −$172,8212021 | $1.8M2025 | +$2.0M | |
| Working capital | $645,5642021 | $2.4M2025 | +$1.7M | |
| Book value per share | $0.152021 | $0.412025 | +28.8%/yr | |
| Current ratio | 2.612021 | 2.512025 | −0.10 | |
| Debt / equity | 0.602021 | 0.372025 | −0.24 | |
| Shares outstanding | 8.1M2021 | 8.4M2025 | +0.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
EXOZ assets
EXOZ liabilities and equity
EXOZ debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
EXOZ balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $3.0M | $9.7M | $66,533 | $558,570 | $547,806 |
| Cash & equivalents | $3.0M | $9.7M | $66,533 | $558,570 | $547,806 |
| Receivables | $517,359 | $737,282 | $882,319 | $809,532 | $468,353 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $382,886 | $363,790 | $264,762 | $101,137 | $30,186 |
| Total current assets | $3.9M | $10.8M | $1.2M | $1.5M | $1.0M |
| Property, plant & equipment (net) | $2.2M | $2.2M | $2.3M | $1.2M | $1.3M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 |
| Total assets | $6.0M | $13.0M | $3.6M | $2.7M | $2.3M |
| Liabilities | |||||
| Accounts payable | $1.2M | $924,252 | $702,911 | $385,796 | $267,296 |
| Short-term debt | $326,234 | $230,027 | $224,988 | $145,003 | $133,485 |
| Total current liabilities | $1.6M | $1.3M | $2.4M | $634,358 | $400,781 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $1.2M | $1.4M | $1.6M | $608,773 | $720,627 |
| Other long-term liabilities | $1.0M | $1.3M | $1.5M | $678,768 | $748,247 |
| Total liabilities | $2.6M | $2.6M | $3.9M | $1.3M | $1.1M |
| Shareholders' equity | |||||
| Common stock & paid-in capital | $8 | $8 | $6 | $6 | $12 |
| Retained earnings (deficit) | −$21.1M | −$11.9M | −$6.1M | −$4.0M | −$2.7M |
| Total shareholders' equity | $3.4M | $10.4M | −$384,319 | $1.4M | $1.2M |
| Key figures | |||||
| Total debt | $1.2M | $1.4M | $1.6M | $608,773 | $720,627 |
| Net cash (debt) | $1.8M | $8.3M | −$1.5M | −$50,203 | −$172,821 |
| Working capital | $2.4M | $9.5M | −$1.2M | $834,881 | $645,564 |
| Tangible book value | $3.4M | $10.4M | −$384,319 | $1.4M | $1.2M |
| Book value per share | $0.41 | $1.28 | −$0.05 | $0.17 | $0.15 |
| Shares outstanding | 8.4M | 8.1M | 8.1M | 8.1M | 8.1M |
| Current ratio | 2.51 | 8.12 | 0.50 | 2.32 | 2.61 |
| Quick ratio | 2.27 | 7.84 | 0.39 | 2.16 | 2.54 |
| Debt / equity | 0.37 | 0.13 | — | 0.44 | 0.60 |
| Equity / assets | 56.9% | 79.9% | −10.8% | 51.1% | 51.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $5.7M | $1.4M | $3.0M | $5.1M | $7.0M | $8.5M | $9.7M | $233,935 | $158,239 | $113,796 | $66,533 | $474,556 |
| Cash & equivalents | $5.7M | $1.4M | $3.0M | $5.1M | $7.0M | $8.5M | $9.7M | $233,935 | $158,239 | $113,796 | $66,533 | $474,556 |
| Receivables | $219,872 | $302,863 | $517,359 | $302,643 | $257,753 | $595,160 | $737,282 | $553,963 | $1.1M | $1.1M | $882,319 | $678,855 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $296,227 | $342,545 | $382,886 | $204,720 | $287,419 | $312,210 | $363,790 | $634,693 | $476,282 | $412,301 | $264,762 | $156,730 |
| Total current assets | $6.2M | $2.1M | $3.9M | $5.6M | $7.5M | $9.4M | $10.8M | $1.4M | $1.8M | $1.6M | $1.2M | $1.3M |
| Property, plant & equipment (net) | $2.0M | $1.8M | $2.2M | $2.0M | $2.1M | $2.1M | $2.2M | $2.1M | $2.3M | $2.4M | $2.3M | $2.1M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $105,205 | $0 | $105,826 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $8.0M | $4.0M | $6.0M | $7.7M | $9.7M | $11.5M | $13.0M | $3.6M | $4.1M | $4.0M | $3.6M | $3.4M |
| Liabilities | ||||||||||||
| Accounts payable | $1.3M | $1.2M | $1.2M | $904,353 | $930,629 | $1.1M | $924,252 | $908,606 | $502,885 | $756,677 | $702,911 | $338,888 |
| Short-term debt | $343,728 | $334,899 | $326,234 | $316,924 | $286,314 | $236,795 | $230,027 | $3.6M | $3.1M | $241,229 | $224,988 | $240,513 |
| Total current liabilities | $1.6M | $1.6M | $1.6M | $1.2M | $1.2M | $1.4M | $1.3M | $5.8M | $4.9M | $3.8M | $2.4M | $1.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | $1.3M | $1.4M | $1.4M | $1.5M | $1.6M | $1.6M | $1.4M |
| Other long-term liabilities | $2.7M | $908,355 | $1.0M | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | $1.4M | $1.5M | $1.5M | $1.3M |
| Total liabilities | $4.3M | $2.5M | $2.6M | $2.3M | $2.4M | $2.6M | $2.6M | $7.2M | $6.3M | $5.3M | $3.9M | $2.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $9 | $8 | $8 | $8 | $8 | $8 | $8 | $6 | $6 | $13 | $6 | $13 |
| Retained earnings (deficit) | −$26.4M | −$23.5M | −$21.1M | −$18.4M | −$16.2M | −$13.8M | −$11.9M | −$10.1M | −$8.5M | −$7.1M | −$6.1M | −$5.0M |
| Total shareholders' equity | $3.7M | $1.5M | $3.4M | $5.4M | $7.2M | $8.9M | $10.4M | −$3.6M | −$2.3M | −$1.2M | −$384,319 | $607,141 |
| Key figures | ||||||||||||
| Total debt | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | $1.3M | $1.4M | $4.9M | $4.4M | $1.6M | $1.6M | $1.4M |
| Net cash (debt) | $4.6M | $279,680 | $1.8M | $3.8M | $5.6M | $7.2M | $8.3M | −$4.6M | −$4.2M | −$1.4M | −$1.5M | −$909,675 |
| Working capital | $4.6M | $507,585 | $2.4M | $4.4M | $6.3M | $8.0M | $9.5M | −$4.4M | −$3.2M | −$2.2M | −$1.2M | −$210,388 |
| Tangible book value | $3.7M | $1.5M | $3.4M | $5.4M | $7.2M | $8.9M | $10.4M | −$3.6M | −$2.3M | −$1.2M | −$384,319 | $607,141 |
| Book value per share | $0.42 | $0.18 | $0.41 | $0.64 | $0.86 | $1.06 | $1.28 | −$0.44 | −$0.28 | −$0.15 | −$0.05 | $0.07 |
| Shares outstanding | 8.7M | 8.5M | 8.4M | 8.4M | 8.4M | 8.4M | 8.1M | 8.1M | 8.1M | 8.1M | 8.1M | 8.1M |
| Current ratio | 3.81 | 1.32 | 2.51 | 4.53 | 6.19 | 6.52 | 8.12 | 0.25 | 0.36 | 0.43 | 0.50 | 0.86 |
| Quick ratio | 3.63 | 1.10 | 2.27 | 4.36 | 5.95 | 6.31 | 7.84 | 0.14 | 0.26 | 0.32 | 0.39 | 0.76 |
| Debt / equity | 0.30 | 0.76 | 0.37 | 0.25 | 0.19 | 0.15 | 0.13 | — | — | — | — | 2.28 |
| Equity / assets | 45.8% | 38.0% | 56.9% | 69.6% | 74.8% | 77.1% | 79.9% | −101.2% | −55.8% | −31.2% | −10.8% | 17.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.
EXOZ financial position
At the end of fiscal 2025 (December 31, 2025), eXoZymes had total assets of $6.0 million (down 54.2% from a year earlier), total liabilities of $2.6 million and shareholders' equity of $3.4 million. It held $3.0 million in cash and short-term investments against $1.2 million of debt, a net cash position of $1.8 million. Its current ratio was 2.51. In the latest quarter (ended June 30, 2026) total assets were $8.0 million and equity $3.7 million.
Related: EXOZ income statement, EXOZ cash flow statement, EXOZ key metrics. See the EXOZ stock overview for the latest quote and news.
EXOZ balance sheet FAQ
What are eXoZymes's total assets?
eXoZymes reported total assets of $6.0 million at the end of fiscal 2025 (December 31, 2025), compared with $13.0 million a year earlier.
How much debt does eXoZymes have?
eXoZymes had $1.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.37.
How much cash does eXoZymes have?
eXoZymes held $3.0 million in cash and short-term investments at the end of fiscal 2025; with $1.2 million of debt that is net cash of $1.8 million.
What is eXoZymes's book value?
eXoZymes's shareholders' equity (book value) was $3.4 million at the end of fiscal 2025, or $0.41 per share.
What is eXoZymes's current ratio?
eXoZymes had current assets of $3.9 million and current liabilities of $1.6 million, a current ratio of 2.51 (it can cover its short-term obligations).